PXS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PXS is not a good buy right now for an impatient investor. The chart is mildly bullish, but momentum is fading and fundamentals are deteriorating sharply (2025/Q3 YoY declines in revenue, net income, and EPS). With no Intellectia buy signals, no supportive news/catalyst flow, and earnings coming up (2026-02-19 pre-market), the risk/reward does not justify buying at ~$3.35 today.
Trend/Setup: Mild bullish trend overall as moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), suggesting the broader trend is up. Momentum: MACD histogram is positive (0.0247) but contracting, implying bullish momentum is weakening rather than accelerating. RSI(6) ~66.97 is neutral-to-warm and close to overbought territory, which limits immediate upside without a pullback. Key levels: Pivot ~3.276. Support: S1 ~3.099 (then S2 ~2.989). Resistance: R1 ~3.453 then R2 ~3.563. With price at ~3.35, it’s closer to resistance than support, making the immediate entry less attractive for a quick move. Short-horizon pattern odds (provided): ~70% chance of -0.94% next day, ~0.07% next week, ~+3.1% next month—near-term edge looks weak.
Intellectia Proprietary Trading Signals
Bullish moving-average alignment suggests the market has been trending upward.
Potential 1-month upside indicated by the provided pattern study (+3.1% expected, probabilistic).
Upcoming earnings (2026-02-19 pre-market) could act as a catalyst if results/forward commentary surprise positively.
than support, reducing favorable immediate upside for an impatient entry.
Latest quarter: 2025/Q3. Revenue: $9.70M, down -29.67% YoY (clear top-line contraction). Net Income: $1.195M, down -66.48% YoY (profitability weakened significantly). EPS: $0.11, down -63.33% YoY (earnings power deteriorated). Gross Margin: 34.93%, down -18.39% YoY (margin compression). Overall: The quarter shows a negative growth trend and weakening margins, which undermines the bullish technical picture.
No analyst rating or price target change data was provided, so a current Wall Street consensus view (pros/cons, upgrades/downgrades, target revisions) cannot be assessed from the dataset. Trading trends provided show Hedge Funds: Neutral (no significant activity last quarter) and Insiders: Neutral (no significant activity last month). Congress trading: no recent data available.
